CLINICAL_TRIALS
trial_result
· 2017-09-06
Clinical Trial Update: Diclofenac for Submassive PE [Phase 2, Phase 3]
Summary
Clinical trial update for diclofenac in submassive pulmonary embolism, involving Phase 2 and Phase 3; the study is terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ministry of Health, Spain | Conditions: Pulmonary Embolism | Phase 2, Phase 3 | Status: TERMINATED